Certified by Founder Lodge 
                                        
                                        FACIT
 Canada  -  Toronto, ON
 
                                                 Canada  -  Toronto, ON 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $10,000,000
                                            1 Participating Investments
- 
                                                Operating Status 
                                                Active 
- 
                                                Last Funding Type 
                                                Seed 
- 
                                                Company Type 
                                                For Profit 
- Website
- Contact
- Social Links
                                            FACIT is a business accelerator and investor established by the Ontario Institute for Cancer Research (OICR) to support the commercialization of Ontario breakthrough cancer innovations that b
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
|  CTRL Therapeutics | April, 27 ,2023 | Seed | $10,000,000 | 
 
                                                 Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. 
 
                                             Ozette Technologies
Ozette Technologies NAPIGEN, INC.
NAPIGEN, INC. TrueBinding
TrueBinding Loopworm
Loopworm 
 
                                             IORGANBIO |  $2,000,000  | (Oct 30, 2025)
                                                                        
                                IORGANBIO |  $2,000,000  | (Oct 30, 2025) Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025)
                                                                        
                                Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025) Vesence |  $9,000,000  | (Oct 30, 2025)
                                                                        
                                Vesence |  $9,000,000  | (Oct 30, 2025) Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025) Reflectiz |  $22,000,000  | (Oct 30, 2025)
                                                                        
                                Reflectiz |  $22,000,000  | (Oct 30, 2025) 
                             
                                                 
                                                 
                                                 
                                                 
                                                 
                                                 
                                                 
                                                 
                                                